Last reviewed · How we verify
Urinary Incontinence due to Detrusor Overactivity
Approved treatments
- Botox · Allergan
BOTOX blocks neuromuscular transmission by inhibiting acetylcholine release through cleavage of SNAP-25.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Urinary Incontinence due to Detrusor Overactivity patent landscape — cliff calendar, originator estates, attackable patents
- Urinary Incontinence due to Detrusor Overactivity treatment landscape brief
- Urinary Incontinence due to Detrusor Overactivity treatment updates RSS
Frequently asked questions about Urinary Incontinence due to Detrusor Overactivity
What drugs treat Urinary Incontinence due to Detrusor Overactivity?
Tracked treatments include Botox.
What is the treatment for Urinary Incontinence due to Detrusor Overactivity?
Standard treatment for Urinary Incontinence due to Detrusor Overactivity includes Botox. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Urinary Incontinence due to Detrusor Overactivity patent cliff · Urinary Incontinence due to Detrusor Overactivity CI report
- Treatment: Botox · Allergan
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing